Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A reliable method was created to measure dutasteride and related molecules in capsules.

High doses of some contraceptive steroids cause health issues in dogs, but their relevance to humans is unclear.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Analog 23 is a promising compound for prostate cancer treatment.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

A new drug strategy improves hair loss treatment with better results and safety.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Thiadiazole chitosan conjugates improve hair manageability, moisture, and protection in conditioners.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Higher 3α,5α-THP levels in the brain may reduce depression in pregnant rats.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Compound 1 showed promising anticancer activity.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Some birth control pills increase blood clot risk; use them for specific conditions only.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.